Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3879313

CC#CCn1c(=O)n(-c2ccc(OC)nc2)c2ncnc(N3CCNCC3)c21.O=C(O)C(F)(F)F

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.39
CHRNA4 P43681 1/20 0.39
MTOR P42345 2/20 0.38
PIK3CD O00329 1/20 0.38
CSNK2A2 P19784 1/20 0.38
FECH P22830 1/20 0.38
PIK3CA P42336 1/20 0.38
PIK3CB P42338 1/20 0.38
PIK3CG P48736 1/20 0.38
CLK1 P49759 1/20 0.38
GSK3A P49840 1/20 0.38
DYRK1A Q13627 1/20 0.38
MELK Q14680 1/20 0.38
MYLK3 Q32MK0 1/20 0.38
PIK3C3 Q8NEB9 1/20 0.38
PIP4K2C Q8TBX8 1/20 0.38
TP53RK Q96S44 1/20 0.38
RPTOR Q8N122 1/20 0.37
MLST8 Q9BVC4 1/20 0.37
DPP4 P27487 9/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1061909 0.93 CHRNB2 (0.44) CHRNB2CHRNA4MTORPIK3CDCSNK2A2
Trifluoroacetic Acid SCHEMBL3888334 0.90 DPP4 (0.36) DPP4FAPHRH4DPP9
Trifluoroacetic Acid SCHEMBL3874248 0.87 DPP4 (0.43) DPP4FAPDPP9
Trifluoroacetic Acid SCHEMBL3888649 0.86 DPP4 (0.38) CHRNB2CHRNA4DPP4FAPHRH4
Trifluoroacetic Acid SCHEMBL3874233 0.85 DPP4 (0.39) DPP4FAPRENHRH4DPP9
Trifluoroacetic Acid SCHEMBL3877495 0.85 DPP4 (0.38) DPP4FAPHRH4DPP9
Trifluoroacetic Acid SCHEMBL3875141 0.84 DPP4 (0.37) DPP4FAPHRH4DPP9
Trifluoroacetic Acid SCHEMBL3879283 0.82 DPP4 (0.38) DPP4FAPHRH4DPP9
SCHEMBL13866969 0.82 DPP4 (0.41) DPP4FAPDPP9
Trifluoroacetic Acid SCHEMBL3881735 0.82 DPP4 (0.48) DPP4FAPHRH4DPP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7524847-B2 Fused 1,3-dihydro-imidazole ring compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-04-28 US disclosed
US-20060111362-A1 1,3-Dihydroimidazole ring compound EISAI CO., LTD. (JP) 2006-05-25 US disclosed
EP-1568699-A1 1,3-DIHYDROIMIDAZOLE FUSED-RING COMPOUND Eisai Co., Ltd. (JP) 2005-08-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060111362-A1 1,3-Dihydroimidazole ring compound NR2C2, NR0B2, DPP4 CHRNB2 526/4885CHRNA4 283/4885MTOR 3766/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.